Transce3nd, LLC Ark Genomic Revolution ETF (De Transaction History

Transce3nd, LLC

$295 Billion
Q4 2024

A detailed history of Transce3nd, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Transce3nd, LLC holds 540 shares of ARKG stock, worth $15,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares

540

Holding current value

$15,913

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	BUY	$22.66 - $27.11 $12,236 - $14,639	540 New	540 $12.7 Million

Others Institutions Holding ARKG

# of Institutions

281

Shares Held

23.3M

Call Options Held

2.91M

Put Options Held

2.5M

Goldman Sachs Group Inc New York, NY

3.63M
Shares

$107 Million
0.01% of portfolio
Morgan Stanley New York, NY

3.48M
Shares

$103 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

2.79M
Shares

$82.3 Million
0.01% of portfolio
Bank Of America Corp Charlotte, NC

2.78M
Shares

$82 Million
0.01% of portfolio
Citigroup Inc

1.66M
Shares

$48.8 Million
0.02% of portfolio

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transce3nd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transce3nd, LLC with notifications on news.

Account